DE69028204D1 - Verfahren zur behandlung von unfruchtbarkeit und dafür verwendbares mittel - Google Patents

Verfahren zur behandlung von unfruchtbarkeit und dafür verwendbares mittel

Info

Publication number
DE69028204D1
DE69028204D1 DE69028204T DE69028204T DE69028204D1 DE 69028204 D1 DE69028204 D1 DE 69028204D1 DE 69028204 T DE69028204 T DE 69028204T DE 69028204 T DE69028204 T DE 69028204T DE 69028204 D1 DE69028204 D1 DE 69028204D1
Authority
DE
Germany
Prior art keywords
treatment
infertility
media used
used therefor
gonadotrophins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028204T
Other languages
English (en)
Other versions
DE69028204T2 (de
Inventor
Howard Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69028204D1 publication Critical patent/DE69028204D1/de
Application granted granted Critical
Publication of DE69028204T2 publication Critical patent/DE69028204T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
DE69028204T 1989-06-02 1990-05-31 Verfahren zur behandlung von unfruchtbarkeit und dafür verwendbares mittel Expired - Fee Related DE69028204T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK272789A DK272789D0 (da) 1989-06-02 1989-06-02 Fremgangsmaade og praeparat til behandling af infertilitet
PCT/DK1990/000133 WO1990014839A1 (en) 1989-06-02 1990-05-31 A process for treating infertility and an agent for use in the process

Publications (2)

Publication Number Publication Date
DE69028204D1 true DE69028204D1 (de) 1996-09-26
DE69028204T2 DE69028204T2 (de) 1997-01-16

Family

ID=8115120

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028204T Expired - Fee Related DE69028204T2 (de) 1989-06-02 1990-05-31 Verfahren zur behandlung von unfruchtbarkeit und dafür verwendbares mittel

Country Status (9)

Country Link
EP (1) EP0474787B1 (de)
JP (1) JP2866196B2 (de)
AT (1) ATE141512T1 (de)
AU (1) AU631660B2 (de)
CA (1) CA2056451A1 (de)
DE (1) DE69028204T2 (de)
DK (2) DK272789D0 (de)
ES (1) ES2090137T3 (de)
WO (1) WO1990014839A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3112172B2 (ja) * 1990-03-16 2000-11-27 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ ベノートスハップ 多嚢胞卵巣疾病の治療
US6489288B1 (en) 1990-03-16 2002-12-03 Applied Research Systems Ars Holding Treatment of polycystic ovarian disease
FR2713933B1 (fr) * 1993-12-16 1996-02-02 Rhone Merieux Méthode de superovulation des femelles bovines, méthode de mise en anoestrus et kit approprié.
AU2002358468A1 (en) * 2001-12-21 2003-07-15 Rigshospitalet Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
US20030186892A1 (en) * 2002-03-28 2003-10-02 Rajneesh Taneja Enhancement of endogenous gonadotropin production
EP2266568A1 (de) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Pharmazeutische Zubereitung enthaltend LHRH-Antagonisten und PDE V Hemmern zur Behandlung von Sexualhormon abhängigen Erkrankungen
EP2266567A1 (de) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Pharmazeutische Zubereitung enthaltend Cetrorelix und PDE V Hemmern zur Behandlung von Sexualhormon abhängige Erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD142421B1 (de) * 1978-12-29 1982-06-30 Jost Bergfeld Verfahren zur herstellung einer hormonkombination zur ovulationsstimulation
EP0161063B1 (de) * 1984-04-03 1991-07-24 Serono Laboratories, Inc. Verfahren zur Herbeiführung der Ovulation
EP0282501A4 (de) * 1986-08-18 1989-11-14 Bunge Australia Regulierung der tierreproduktion.
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5017557A (en) * 1987-07-24 1991-05-21 Industria Farmaceutica Serono S.P.A. Treatment of infertility with somatotrophin releasing factor

Also Published As

Publication number Publication date
DK0474787T3 (da) 1996-09-16
ES2090137T3 (es) 1996-10-16
JPH04505921A (ja) 1992-10-15
EP0474787B1 (de) 1996-08-21
ATE141512T1 (de) 1996-09-15
JP2866196B2 (ja) 1999-03-08
DE69028204T2 (de) 1997-01-16
EP0474787A1 (de) 1992-03-18
CA2056451A1 (en) 1990-12-03
WO1990014839A1 (en) 1990-12-13
DK272789D0 (da) 1989-06-02
AU631660B2 (en) 1992-12-03
AU5814990A (en) 1991-01-07

Similar Documents

Publication Publication Date Title
DE3786169D1 (de) Verfahren und einrichtung fuer die behandlung von abgasen durch bestrahlen mit elektronenstrahlen.
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE69033487T2 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
DE68910051D1 (de) Verfahren zur herstellung von aloe-erzeugnissen.
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
MX9205240A (es) Composicion y metodo para tratar hepatitis c.
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE69715000T2 (de) Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
ATE91628T1 (de) Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweggeschw¨rkrankheiten.
DE69028204D1 (de) Verfahren zur behandlung von unfruchtbarkeit und dafür verwendbares mittel
DE68917433D1 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DE3872614D1 (de) Verfahren zur behandlung der unfruchtbarkeit und mittel zur verwendung dabei.
DE3381624D1 (de) Mittel zur behandlung von wunden.
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
ATE187648T1 (de) Zusammensetzungen enthaltend lipoprotein- associated-coagulation-inhibitor (laci) zur herstellung eines medikaments zur behandlung von akuten oder chronischen enzündungen
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE202935T1 (de) Verfahren zur behandlung von haarausfall
ES2106183T3 (es) Suero antiveneno.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
ATE110961T1 (de) Behandlung von beatmungsabhängigkeit mit wachstumshormon.
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
DE58902466D1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.
PT88090A (pt) Processo para o tratamento da infertilidade e para a preparacao de uma composicao utilizada nesse tratamento
MY109685A (en) Method for treating hepatitis b carriers with minimal disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee